Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 16;9(7):1518.
doi: 10.3390/microorganisms9071518.

Microbiological and Molecular Diagnosis of Mucormycosis: From Old to New

Affiliations
Review

Microbiological and Molecular Diagnosis of Mucormycosis: From Old to New

Nina Lackner et al. Microorganisms. .

Abstract

Members of the order Mucorales may cause severe invasive fungal infections (mucormycosis) in immune-compromised and otherwise ill patients. Diagnosis of Mucorales infections and discrimination from other filamentous fungi are crucial for correct management. Here, we present an overview of current state-of-the-art mucormycosis diagnoses, with a focus on recent developments in the molecular field. Classical diagnostic methods comprise histology/microscopy as well as culture and are still the gold standard. Newer molecular methods are evolving quickly and display great potential in early diagnosis, although standardization is still missing. Among them, quantitative PCR assays with or without melt curve analysis are most widely used to detect fungal DNA in clinical samples. Depending on the respective assay, sequencing of the resulting PCR product can be necessary for genus or even species identification. Further, DNA-based methods include microarrays and PCR-ESI-MS. However, general laboratory standards are still in development, meaning that molecular methods are currently limited to add-on analytics to culture and microscopy.

Keywords: DNA; Mucorales; PCR; clinical evaluation; culture; diagnosis; microscopy; sensitivity; specificity; standardization.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest with this manuscript.

Figures

Figure 1
Figure 1
Broad, ribbon-like, non-septate hyphae of Mucor sp. with wide-angle branching, stained with fluorescent brightener (Calcofluor White × 400).
Figure 2
Figure 2
Overview of major molecular methods and their advantages and disadvantages.

Similar articles

Cited by

References

    1. Lackner M., Caramalho R., Lass-Flörl C. Laboratory diagnosis of mucormycosis: Current status and future perspectives. Future Microbiol. 2014;9:683–695. doi: 10.2217/fmb.14.23. - DOI - PubMed
    1. Skiada A., Lass-Floerl C., Klimko N., Ibrahim A., Roilides E., Petrikkos G. Challenges in the diagnosis and treatment of mucormycosis. Med. Mycol. 2018;56:93–101. doi: 10.1093/mmy/myx101. - DOI - PMC - PubMed
    1. Jenks J.D., Gangneux J.-P., Schwartz I.S., Alastruey-Izquierdo A., Lagrou K., Thompson Iii G.R., Lass-Flörl C., Hoenigl M. Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement. J. Fungi. 2020;6 doi: 10.3390/jof6040216. - DOI - PMC - PubMed
    1. Cornely O.A., Alastruey-Izquierdo A., Arenz D., Chen S.C.A., Dannaoui E., Hochhegger B., Hoenigl M., Jensen H.E., Lagrou K., Lewis R.E., et al. Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect. Dis. 2019;19:e405–e421. doi: 10.1016/S1473-3099(19)30312-3. - DOI - PubMed
    1. Lass-Flörl C., Samardzic E., Knoll M. Serology anno 2021-fungal infections: From invasive to chronic. Clin. Microbiol. Infect. 2021 doi: 10.1016/j.cmi.2021.02.005. - DOI - PubMed

LinkOut - more resources